Clarithromycin Tablet
Product Images NDC 76420-051

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Clarithromycin (NDC 76420-051). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clarithrofigure2 (Clarithromycinfigure2)

This appears to be a graph depicting the mean plasma concentration (mcg/mL) of two types of Clarithromycin medication - Clarithromycin Extended-release (2 x 500 mg g24h) and Clarithromycin (500 mg q12h) - over a period of 24 hours. The x-axis represents time after dosing (in hours) and the y-axis represents the mean plasma concentration.*

FDA Label Image

Chemicalstructure (Clarithromycin)

FDA Label Image

Figure3 (Figure3)

The text is describing a graph or chart showing the proportion of survival for two groups, one treated with clarithromycin and the other with a placebo. The x-axis represents the number of days since randomization and the y-axis represents the proportion surviving. There are also numerical values displayed on the x-axis, ranging from 0 to 700.*

FDA Label Image

Image Description (Label 500mg)

This appears to be a collection of labels and packaging information for Clarithromycin Tablets, USP 500mg distributed by Sandoz Inc. There are different quantities provided (14 and 20) and NDC codes (76420-051-14 and 76420-051-20) but the basic details such as drug status (RX), dosage, and storage and dispensing warnings are consistent across the labels.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.